We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMB icon
201
Kimberly-Clark
KMB
$37.3B
$363K 0.01%
+2,548
New +$361K
PPLI
202
People Inc
PPLI
$3.28B
$349K 0.01%
+7,899
New +$329K
TAP icon
203
Molson Coors Class B
TAP
$7.85B
$336K 0.01%
+5,836
New +$312K
OKTA icon
204
Okta
OKTA
$25.6B
$308K ﹤0.01%
+4,139
New +$362K
BEATW icon
205
Heartbeam Inc Warrant
BEATW
$59.1K
$300K ﹤0.01%
500,000
– –
ATXI
206
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$286K ﹤0.01%
115,000
+40,000
+53% +$115K
SHW icon
207
Sherwin-Williams
SHW
$89.7B
$276K ﹤0.01%
+723
New +$252K
ABNB icon
208
Airbnb
ABNB
$90.5B
$275K ﹤0.01%
+2,165
New +$281K
RBLX icon
209
Roblox
RBLX
$25.9B
$245K ﹤0.01%
+5,546
New +$231K
NXGLW icon
210
NexGel Inc Warrant
NXGLW
$31.4K
$241K ﹤0.01%
550,000
– –
BKYI
211
BIO-key International
BKYI
$4.38M
$240K ﹤0.01%
+25,000
New +$360K
PCTY icon
212
Paylocity
PCTY
$7.91B
$235K ﹤0.01%
+1,424
New +$217K
BIAFW icon
213
bioAffinity Technologies
BIAFW
$112K
$235K ﹤0.01%
204,082
– –
MPU icon
214
Mega Matrix
MPU
$14.8M
$222K ﹤0.01%
+220,000
New +$414K
IVDA icon
215
Iveda Solutions
IVDA
$3.41M
$217K ﹤0.01%
+130,000
New +$403K
GIL icon
216
Gildan
GIL
$10.8B
$207K ﹤0.01%
+4,384
New +$185K
CMCSA icon
217
Comcast
CMCSA
$87.8B
$206K ﹤0.01%
+4,920
New +$194K
PRMW
218
DELISTED
Primo Water Corporation
PRMW
$202K ﹤0.01%
+8,005
New +$179K
CAVA icon
219
CAVA Group
CAVA
$7.71B
$201K ﹤0.01%
1,624
-40,472
-96% -$4.11M
PALI icon
220
Palisade Bio
PALI
$368M
$185K ﹤0.01%
52,000
+24,142
+87% +$93K
AAL icon
221
American Airlines Group
AAL
$11B
$184K ﹤0.01%
+16,407
New +$174K
STKH
222
Steakholder Foods
STKH
$1.52M
$180K ﹤0.01%
501
+277
+124% +$96.6K
APCXW
223
DELISTED
AppTech Payments Corp Warrant
APCXW
$171K ﹤0.01%
715,000
– –
FEED
224
ENvue Medical Inc
FEED
$2.38M
$171K ﹤0.01%
2,534
+1,290
+104% +$93.8K
MTEKW icon
225
Maris-Tech Ltd Warrants
MTEKW
$1.16M
$170K ﹤0.01%
1,261,058
– –
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.